Adjuvant and first line chemotherapy use for endometrial cancer

OBJECTIVE: The objective of this study was to describe patterns of utilization of cytotoxic, hormonal, and immunotherapy in patients with endometrial cancer in the adjuvant setting and at the time of first recurrence. METHODS: We identified patients in the IBM MarketScan database with endometrial ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Knisely, Anne, Huang, Yongmei, Li, Yeran, Prabhu, Vimalanand S., Wright, Jason D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126968/
https://www.ncbi.nlm.nih.gov/pubmed/35620299
http://dx.doi.org/10.1016/j.gore.2022.101002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126968/
https://www.ncbi.nlm.nih.gov/pubmed/35620299
http://dx.doi.org/10.1016/j.gore.2022.101002

Ejemplares similares